Global Injectable Drug Delivery Devices Pipeline Assessment Report 2020 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Injectable Drug Delivery Devices – Medical Devices Pipeline Assessment, 2020” report has been added to ResearchAndMarkets.com’s offering.

“Injectable Drug Delivery Devices – Medical Devices Pipeline Assessment, 2020”. Injectable Drug Delivery Devices are defined as administration of a drug into patient’s blood through a delivery device.

Scope

• Extensive coverage of the Injectable Drug Delivery Devices under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Injectable Drug Delivery Devices and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Identify and understand important and diverse types of Injectable Drug Delivery Devices under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product’s current stage of development, territory and estimated launch date

(Read more…)

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Injectable Drug Delivery Overview

3 Products under Development

3.1 Injectable Drug Delivery – Pipeline Products by Stage of Development

3.2 Injectable Drug Delivery – Pipeline Products by Segment

3.3 Injectable Drug Delivery – Pipeline Products by Territory

3.4 Injectable Drug Delivery – Pipeline Products by Regulatory Path

3.5 Injectable Drug Delivery – Pipeline Products by Estimated Approval Date

3.6 Injectable Drug Delivery – Ongoing Clinical Trials

4 Injectable Drug Delivery – Pipeline Products under Development by Companies

4.1 Injectable Drug Delivery Companies – Pipeline Products by Stage of Development

4.2 Injectable Drug Delivery – Pipeline Products by Stage of Development

5 Injectable Drug Delivery Companies and Product Overview

6 Injectable Drug Delivery- Recent Developments 2137 Appendix

7 Appendix

Companies Mentioned

• Adalvo
• Adamis Pharmaceuticals Corp
• AdrenaCard, Inc.
• AktiVax Inc.
• Allergan Ltd
• Alsensa ApS
• Antares Pharma Inc
• Aquavit Pharmaceuticals Inc
• Artemes Technologies, Inc.
• Ascendis Pharma A/S
• ASCIL Biopharm
• ASIS Corp
• AzureBio SL
• Bespak Europe Ltd
• Biocorp Production SA
• 1BioCorRx Inc
• BioRestorative Therapies Inc
• Bioxis Pharmaceuticals
• Brigham and Women’s Hospital
• Burke Pharmaceuticals LLC
• Calla Health Foundation
• Callisyn Biomedical Inc
• Cambridge Consultants Ltd
• Camurus AB
• Case Western Reserve University
• Cincinnati Children’s Hospital Medical Center
• Clearside BioMedical Inc
• DALI Medical Devices Ltd.
• DelSite, Inc. (Inactive)
• Drexel University
• Duoject Medical Systems Inc
• Ecole Polytechnique Federale de Lausanne
• Elcam Medical
• EmboMedics Inc
• Embryyo Technologies Pvt Ltd
• Emergent BioSolutions Inc
• EP Global Communications Inc (Inactive)
• Eveon SAS
• EyePoint Pharmaceuticals Inc
• FHC Inc
• GeneSYS-ID Inc
• Georgia Institute of Technology
• Ghent University
• Globe Medical Tech Inc (Inactive)
• Hoffmann-La Roche Inc
• Inovio Pharmaceuticals Inc
• InVivo Therapeutics Corp
• Ionic Pharmaceuticals LLC
• JCR Pharmaceuticals Co Ltd
• komarik
• Kyowa Kirin Ltd
• Lohmann Therapie-Systeme AG
• 5LyoGo
• Mallinckrodt Plc
• Mercator MedSystems Inc
• Mertiva AB
• Midas Pharma GmbH
• Milestone Scientific Inc
• 5Millendo Therapeutics Inc
• Morimoto Pharma Co Ltd
• NanoPass Technologies Ltd
• Novo Nordisk AS
• Novosanis NV
• Osteo Pharma BV
• Oval Medical Technologies Ltd
• Owen Mumford Ltd
• Palatin Technologies Inc
• Particle Therapeutics Ltd
• Portal Instruments Inc
• Prohibix LLC
• QuiO Technologies LLC
• Regeneron Pharmaceuticals Inc
• RepliCel Life Sciences Inc
• Rescitech Vision Pvt Ltd
• RetinaPharma Technologies Inc
• Sapporo Medical University School of Medicine
• Schott AG
• Subcuject ApS
• Sunshine Guojian Pharmaceutical Shanghai Co Ltd
• Takeda Pharmaceutical Co Ltd
• TCB medical devices
• Terumo Corp
• Teva Pharmaceutical Industries Ltd
• TheraKine Inc (Inactive)
• Twin Star Medical Inc
• Unilife Corporation
• University of Calgary
• University of California San Diego
• University of California San Francisco
• University of Delaware
• University of Dundee
• University of Florida
• University of New Mexico
• University of Saskatchewan
• University of Texas at Austin
• Vanderbilt University
• West Pharmaceutical Services Inc
• Windgap Medical Inc
• XERIS Pharmaceuticals Inc
• Ypsomed Holding AG
• Zosano Pharma Corp

For more information about this report visit https://www.researchandmarkets.com/r/pdw4og

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900